(Q50767866)

18 March 2018

title

Different regional dynamics of end-stage renal disease in Japan by different causes. (English)

1 reference

18 March 2018

1 reference

Nobuo Kato

1

1 reference

18 March 2018

Takeshi Usami

2

1 reference

18 March 2018

Michio Fukuda

3

1 reference

18 March 2018

Masahiro Motokawa

4

1 reference

18 March 2018

Yoshinobu Kamiya

5

1 reference

18 March 2018

Atsuhiro Yoshida

6

1 reference

18 March 2018

Genjiro Kimura

7

1 reference

18 March 2018

publication date

1 August 2005

1 reference

18 March 2018

published in

Nephrology

1 reference

18 March 2018

volume

10

1 reference

18 March 2018

issue

4

1 reference

18 March 2018

page(s)

400-404

1 reference

18 March 2018

Regional variations in the incidence of end-stage renal failure in Japan

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00404.X

Regional variation in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00404.X

Maps of end-stage renal disease and amounts of angiotensin-converting enzyme inhibitors prescribed in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00404.X

Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00404.X

Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00404.X

End-stage renal disease in US minority groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00404.X

No effect of enalapril on progression in autosomal dominant polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00404.X

Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal-dominant polycystic kidney disease: results of a seven-year prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00404.X

The effect of angiotensin-converting-enzyme inhibitors on progression of advanced polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00404.X

Diuretics versus angiotensin-converting enzyme inhibitors in autosomal dominant polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00404.X

Racial Differences in the Progression from Chronic Renal Insufficiency to End-Stage Renal Disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00404.X

10.1111/J.1440-1797.2005.00404.X

21 January 2018

Identifiers

DOI

1 reference

18 March 2018

1 reference

18 March 2018